A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...
Expression of CD44 and CD133 in tumor сells of metastatic and non-metastatic gastric cancer. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not include a full ...
Clinical characteristics and outcome of cancer patients with tuberculosis. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.
Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1, also referred to as hypoplasminogenemia, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results